136 related articles for article (PubMed ID: 35914370)
1. Metabolic reprogramming by adenosine antagonism and implications in non-small cell lung cancer therapy.
Guan S; Suman S; Amann JM; Wu R; Carbone DP; Wang J; Dikov MM
Neoplasia; 2022 Oct; 32():100824. PubMed ID: 35914370
[TBL] [Abstract][Full Text] [Related]
2. Subtle Structural Changes across the Boundary between A
Wang H; Yang X; Li Y; Ze S; Feng B; Weng Y; Gao A; Song G; Liu M; Xie Q; Wang Y; Lu W
J Med Chem; 2024 Mar; 67(6):5075-5092. PubMed ID: 38483150
[TBL] [Abstract][Full Text] [Related]
3. A
Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor is involved in cell surface expression of A2B receptor.
Moriyama K; Sitkovsky MV
J Biol Chem; 2010 Dec; 285(50):39271-88. PubMed ID: 20926384
[TBL] [Abstract][Full Text] [Related]
5. Structural insight into the dual-antagonistic mechanism of AB928 on adenosine A
Weng Y; Yang X; Zhang Q; Chen Y; Xu Y; Zhu C; Xie Q; Wang Y; Yang H; Liu M; Lu W; Song G
Sci China Life Sci; 2024 May; 67(5):986-995. PubMed ID: 38319473
[TBL] [Abstract][Full Text] [Related]
6. Activation of adenosine A
Sun C; Jiao T; Merkus D; Duncker DJ; Mustafa SJ; Zhou Z
J Pharmacol Sci; 2019 Sep; 141(1):64-69. PubMed ID: 31640919
[TBL] [Abstract][Full Text] [Related]
7. The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8
Chen S; Akdemir I; Fan J; Linden J; Zhang B; Cekic C
Cancer Immunol Res; 2020 Aug; 8(8):1064-1074. PubMed ID: 32381524
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A
Yu F; Zhu C; Xie Q; Wang Y
J Med Chem; 2020 Nov; 63(21):12196-12212. PubMed ID: 32667814
[TBL] [Abstract][Full Text] [Related]
9. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
[TBL] [Abstract][Full Text] [Related]
10. Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist.
Bai Y; Zhang X; Zheng J; Liu Z; Yang Z; Zhang X
J Exp Clin Cancer Res; 2022 Oct; 41(1):302. PubMed ID: 36229853
[TBL] [Abstract][Full Text] [Related]
11. Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts.
Chen Y; Epperson S; Makhsudova L; Ito B; Suarez J; Dillmann W; Villarreal F
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2478-86. PubMed ID: 15284071
[TBL] [Abstract][Full Text] [Related]
12. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
[TBL] [Abstract][Full Text] [Related]
13. A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.
Mediavilla-Varela M; Castro J; Chiappori A; Noyes D; Hernandez DC; Allard B; Stagg J; Antonia SJ
Neoplasia; 2017 Jul; 19(7):530-536. PubMed ID: 28582704
[TBL] [Abstract][Full Text] [Related]
14. Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression.
Evans JV; Suman S; Goruganthu MUL; Tchekneva EE; Guan S; Arasada RR; Antonucci A; Piao L; Ilgisonis I; Bobko AA; Driesschaert B; Uzhachenko RV; Hoyd R; Samouilov A; Amann J; Wu R; Wei L; Pallerla A; Ryzhov SV; Feoktistov I; Park KP; Kikuchi T; Castro J; Ivanova AV; Kanagasabai T; Owen DH; Spakowicz DJ; Zweier JL; Carbone DP; Novitskiy SV; Khramtsov VV; Shanker A; Dikov MM
J Natl Cancer Inst; 2023 Nov; 115(11):1404-1419. PubMed ID: 37195421
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.
Leone RD; Sun IM; Oh MH; Sun IH; Wen J; Englert J; Powell JD
Cancer Immunol Immunother; 2018 Aug; 67(8):1271-1284. PubMed ID: 29923026
[TBL] [Abstract][Full Text] [Related]
16. Unlocking antitumor immunity with adenosine receptor blockers.
Remley VA; Linden J; Bauer TW; Dimastromatteo J
Cancer Drug Resist; 2023; 6(4):748-767. PubMed ID: 38263981
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
[TBL] [Abstract][Full Text] [Related]
18. Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells.
Campos-Contreras ADR; González-Gallardo A; Díaz-Muñoz M; Vázquez-Cuevas FG
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562985
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system.
Christofi FL; Zhang H; Yu JG; Guzman J; Xue J; Kim M; Wang YZ; Cooke HJ
J Comp Neurol; 2001 Oct; 439(1):46-64. PubMed ID: 11579381
[TBL] [Abstract][Full Text] [Related]
20. A
Alter C; Ding Z; Flögel U; Scheller J; Schrader J
Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H190-H200. PubMed ID: 31050560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
